Because we found the increase in number of K8+K14+ progenitor cells in resistant tumors that overexpress Zfp217, we reasoned that this population might be eliminated by treatment, which ultimately would reduce tumor burden if these K8+K14+ cells are the therapy-resistant repopulating cells of the tumor. The gene discussed is KRT14; the disease is neoplasm.